AtriCure (ATRC) COO adds ESPP shares in routine acquisition
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
AtriCure, Inc. Chief Operating Officer Douglas J. Seith acquired 527 shares of common stock through the company’s 2018 Employee Stock Purchase Plan for the period ended June 30, 2026. The shares were purchased at $23.78 each, bringing his direct holdings to 229,867 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Seith Douglas J
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 527 | $23.78 | $13K |
Holdings After Transaction:
Common Stock — 229,867 shares (Direct, null)
Footnotes (1)
- Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026. In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.
Key Figures
Shares acquired: 527 shares
Purchase price per share: $23.78 per share
Closing market price: $27.98 per share
+2 more
5 metrics
Shares acquired
527 shares
Common stock acquired via 2018 ESPP for period ended June 30, 2026
Purchase price per share
$23.78 per share
ESPP acquisition price reported in Form 4
Closing market price
$27.98 per share
Closing price on June 30, 2026 used for ESPP discount
Holdings after transaction
229,867 shares
Direct AtriCure common stock held by COO after ESPP purchase
ESPP discount rate
85% of closing price
Plan formula applied to June 30, 2026 closing price
Key Terms
Employee Stock Purchase Plan, ESPP, closing price, grant/award acquisition
4 terms
Employee Stock Purchase Plan financial
"Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
ESPP financial
"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026."
An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.
closing price financial
"The closing price on June 30, 2026, was $27.98."
grant/award acquisition financial
"transaction_action": "grant/award acquisition""
FAQ
What did AtriCure (ATRC) COO Douglas Seith report on this Form 4?
Douglas J. Seith reported acquiring 527 shares of AtriCure common stock. The acquisition came through the 2018 Employee Stock Purchase Plan for the period ended June 30, 2026, and increased his direct holdings to 229,867 shares.
What discount applied to the AtriCure (ATRC) COO’s ESPP purchase?
Under the employee stock purchase plan, the COO’s shares were purchased at 85% of the June 30, 2026 closing price. The closing price was $27.98, and the resulting purchase price for this acquisition was $23.78 per share, as reflected in the Form 4.
What are Douglas Seith’s AtriCure (ATRC) holdings after this Form 4?
Following this ESPP acquisition, Douglas J. Seith directly holds 229,867 AtriCure common shares. This figure reflects his position after adding the 527 shares purchased for the employee stock purchase plan period ended June 30, 2026.